These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

329 related items for PubMed ID: 2178909

  • 1. Clomipramine. An overview of its pharmacological properties and a review of its therapeutic use in obsessive compulsive disorder and panic disorder.
    McTavish D, Benfield P.
    Drugs; 1990 Jan; 39(1):136-53. PubMed ID: 2178909
    [Abstract] [Full Text] [Related]

  • 2. Paroxetine : a review of its pharmacology and therapeutic potential in the management of panic disorder.
    Foster RH, Goa KL.
    CNS Drugs; 1997 Aug; 8(2):163-88. PubMed ID: 23338224
    [Abstract] [Full Text] [Related]

  • 3. Efficacy of drug treatment in obsessive-compulsive disorder. A meta-analytic review.
    Piccinelli M, Pini S, Bellantuono C, Wilkinson G.
    Br J Psychiatry; 1995 Apr; 166(4):424-43. PubMed ID: 7795913
    [Abstract] [Full Text] [Related]

  • 4. Antidepressant drugs in anxiety disorders.
    Modigh K.
    Acta Psychiatr Scand Suppl; 1987 Apr; 335():57-74. PubMed ID: 3314359
    [Abstract] [Full Text] [Related]

  • 5. Clomipramine: an antiobsessional tricyclic antidepressant.
    Peters MD, Davis SK, Austin LS.
    Clin Pharm; 1990 Mar; 9(3):165-78. PubMed ID: 2180623
    [Abstract] [Full Text] [Related]

  • 6.
    Swedish Council on Health Technology Assessment.
    ; 2005 11. PubMed ID: 28876726
    [Abstract] [Full Text] [Related]

  • 7. Worldwide use of clomipramine.
    Trimble MR.
    J Clin Psychiatry; 1990 Aug; 51 Suppl():51-4; discussion 55-8. PubMed ID: 2199435
    [Abstract] [Full Text] [Related]

  • 8. Fluvoxamine versus clomipramine in the treatment of obsessive compulsive disorder: a multicenter, randomized, double-blind, parallel group comparison.
    Freeman CP, Trimble MR, Deakin JF, Stokes TM, Ashford JJ.
    J Clin Psychiatry; 1994 Jul; 55(7):301-5. PubMed ID: 8071291
    [Abstract] [Full Text] [Related]

  • 9. Effect of serotonin uptake inhibitors in anxiety disorders; a double-blind comparison of clomipramine and fluvoxamine.
    den Boer JA, Westenberg HG, Kamerbeek WD, Verhoeven WM, Kahn RS.
    Int Clin Psychopharmacol; 1987 Jan; 2(1):21-32. PubMed ID: 3117876
    [Abstract] [Full Text] [Related]

  • 10. Tricyclic antidepressants in obsessive-compulsive disorder: antiobsessional or antidepressant agents? II.
    Mavissakalian M, Turner SM, Michelson L, Jacob R.
    Am J Psychiatry; 1985 May; 142(5):572-6. PubMed ID: 3885761
    [Abstract] [Full Text] [Related]

  • 11. Effect of a serotonin precursor and uptake inhibitor in anxiety disorders; a double-blind comparison of 5-hydroxytryptophan, clomipramine and placebo.
    Kahn RS, Westenberg HG, Verhoeven WM, Gispen-de Wied CC, Kamerbeek WD.
    Int Clin Psychopharmacol; 1987 Jan; 2(1):33-45. PubMed ID: 3312397
    [Abstract] [Full Text] [Related]

  • 12. Clomipramine in the treatment of patients with obsessive-compulsive disorder. The Clomipramine Collaborative Study Group.
    Arch Gen Psychiatry; 1991 Aug; 48(8):730-8. PubMed ID: 1883256
    [Abstract] [Full Text] [Related]

  • 13. Clomipramine for obsessive-compulsive disorder.
    Feinberg M.
    Am Fam Physician; 1991 May; 43(5):1735-8. PubMed ID: 2021107
    [Abstract] [Full Text] [Related]

  • 14. Effects of imipramine on depression and obsessive-compulsive symptoms.
    Foa EB, Steketee G, Kozak MJ, Dugger D.
    Psychiatry Res; 1987 Jun; 21(2):123-36. PubMed ID: 3615688
    [Abstract] [Full Text] [Related]

  • 15. Fluvoxamine. An updated review of its use in the management of adults with anxiety disorders.
    Figgitt DP, McClellan KJ.
    Drugs; 2000 Oct; 60(4):925-54. PubMed ID: 11085201
    [Abstract] [Full Text] [Related]

  • 16. [Obsessive-compulsive symptoms associated with panic disorder. Predictive factor of a good therapeutic response to fluvoxamine].
    Servant D, Bailly D, Le Seac'h H, Parquet PJ.
    Encephale; 1990 Oct; 16 Spec No():359-62. PubMed ID: 2120029
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Treatment of obsessive-compulsive disorder with clomipramine and desipramine in children and adolescents. A double-blind crossover comparison.
    Leonard HL, Swedo SE, Rapoport JL, Koby EV, Lenane MC, Cheslow DL, Hamburger SD.
    Arch Gen Psychiatry; 1989 Dec; 46(12):1088-92. PubMed ID: 2686576
    [Abstract] [Full Text] [Related]

  • 20. Pharmacologic treatment of anxiety disorders.
    Mavissakalian M.
    J Clin Psychiatry; 1982 Dec; 43(12):487-91. PubMed ID: 6131065
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.